STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICUI
  4. [144] ICU MEDICAL INC/DE SEC Filing

ICU Medical (ICUI) files Form 144 for planned sale of 8,929 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ICU Medical, Inc. (ICUI) has a planned resale of 8,929 shares of common stock, handled through Morgan Stanley Smith Barney LLC Executive Financial Services and listed on NASDAQ. The filing lists an aggregate market value of approximately $1,633,403.62 for these shares, compared with 25,007,038 shares of common stock outstanding. The shares relate to previously exercised options in May 2025 and equity awards (restricted stock and performance stock units) vesting on March 15, 2026, with an approximate sale date of August 11, 2026.

Positive

  • None.

Negative

  • None.
Shares to be sold 8,929 shares Common stock covered by the Form 144 resale notice
Aggregate market value $1,633,403.62 Value of the 8,929 ICUI shares proposed to be sold
Shares outstanding 25,007,038 shares ICU Medical common shares outstanding referenced in the filing
Approximate sale date 08/11/2026 Planned date for the resale of ICUI shares on NASDAQ
Option-related shares 596; 596; 610; 575 shares Shares from previously exercised options dated May 22–28, 2025
Restricted stock vesting 1,453 shares Restricted stock vesting under a registered plan on March 15, 2026
Performance stock units 5,099 shares Shares tied to performance stock units dated March 15, 2026
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Previously Exercised Options financial
"Common | 05/22/2025 | Previously Exercised Options | Issuer"
Restricted Stock Vesting Under a Registered Plan financial
"Common | 03/15/2026 | Restricted Stock Vesting Under a Registered Plan"
Performance Stock Units financial
"Common | 03/15/2026 | Performance Stock Units | Issuer"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
aggregate market value financial
"8929 | 1633403.62 | 25007038 | 08/11/2026 | NASDAQ"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does ICUI's Form 144 filing disclose?
The Form 144 for ICUI discloses a planned resale of 8,929 shares of common stock with an aggregate market value of about $1,633,403.62, to be sold on NASDAQ around August 11, 2026.

How many ICUI shares are planned for sale under this Form 144?
The filing reports a planned sale of 8,929 shares of ICU Medical common stock. These shares are tied to stock option exercises in May 2025 and restricted stock and performance stock unit vesting on March 15, 2026.

What is the aggregate market value of the ICUI shares in this Form 144?
The reported aggregate market value of the 8,929 ICUI shares is approximately $1,633,403.62. This reflects the value of the securities covered by the notice of proposed sale, rather than the company’s total market capitalization.

How many ICUI shares are outstanding compared to those being sold?
The filing lists 25,007,038 shares of ICUI common stock outstanding, versus 8,929 shares covered by the planned resale. This indicates the Form 144 transaction relates to a small portion of the total outstanding shares.

What types of ICUI equity awards are involved in this Form 144?
The Form 144 notes shares associated with previously exercised options, restricted stock vesting under a registered plan, and performance stock units vesting on March 15, 2026, all issued by ICU Medical as the issuer.

When were the ICUI options and awards underlying this Form 144 activity dated?
Related option exercises are dated May 22, 23, 27, and 28, 2025. Restricted stock and performance stock units are noted with a vesting date of March 15, 2026, ahead of the approximate sale date of August 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR